Aquilo Capital Management, LLC - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
Aquilo Capital Management, LLC ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$6,806,000
+72.6%
3,403,210
-36.0%
2.45%
+82.2%
Q2 2022$3,943,000
-91.4%
5,321,231
+0.8%
1.35%
-80.1%
Q1 2022$45,949,000
-42.2%
5,281,504
+6.4%
6.75%
-25.1%
Q4 2021$79,477,000
-5.4%
4,964,181
+8.8%
9.01%
-40.9%
Q3 2021$84,017,000
+57.2%
4,563,688
+19.2%
15.26%
+9.9%
Q2 2021$53,456,000
-5.2%
3,829,2090.0%13.89%
+36.4%
Q1 2021$56,366,000
-26.1%
3,829,209
-2.6%
10.19%
-35.7%
Q4 2020$76,246,000
+51.9%
3,932,209
-12.6%
15.85%
+198.2%
Q3 2020$50,188,000
+90.9%
4,497,142
+131.4%
5.31%
+0.2%
Q2 2020$26,290,000
+79.0%
1,943,081
+6.9%
5.30%
-7.4%
Q1 2020$14,691,000
+32.4%
1,818,140
+57.5%
5.73%
+37.3%
Q4 2019$11,099,000
-9.3%
1,154,3560.0%4.17%
-51.6%
Q3 2019$12,236,000
-7.9%
1,154,3560.0%8.62%
+86.8%
Q2 2019$13,287,000
-1.6%
1,154,356
+9.5%
4.61%
-22.9%
Q1 2019$13,506,000
+112.8%
1,054,356
+2.2%
5.98%
+94.7%
Q4 2018$6,346,0001,031,9473.07%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,376,968$13,247,00023.08%
Aquilo Capital Management, LLC 1,154,356$11,099,0004.17%
VHCP Management II, LLC 474,015$4,558,0001.20%
AWM Investment Company, Inc. 474,344$4,561,0000.89%
Alphabet Inc. 1,112,473$10,696,0000.65%
BVF INC/IL 845,405$8,129,0000.62%
Novo Holdings A/S 931,099$8,948,0000.58%
Artal Group S.A. 500,000$4,808,0000.19%
Rock Springs Capital Management LP 525,000$5,048,0000.16%
Granahan Investment Management 148,867$1,431,0000.07%
View complete list of SPERO THERAPEUTICS INC shareholders